MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0069544
Kopran Laboratories Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹112.82 Cr
▲ 9% YoY
Net profit · FY 2025
₹20.99 Cr
Net margin 18.6%
EBITDA · FY 2025
₹33.74 Cr
EBITDA margin 29.9%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹5.3 Cr
Issued & subscribed
Open charges
₹52.24 Cr
Satisfied ₹45.24 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
59
Provident fund records
About Kopran Laboratories Limited
Data last updated:
Kopran Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 12 August 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1986PLC040602. Its GSTIN is 27AAACK4406H3ZQ (Maharashtra). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹5.3 Cr. It was formerly known as Kopran Laboratories Private Limited. It is led by directors including Varun Surendra Somani (Managing Director) and Surendran Nair.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Parijat House1076 Dr E Moses Rd Worli, Mumbai, Maharashtra, India – 400018.
As per the financials filed for FY 2025, the company reported a revenue of ₹112.82 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹20.99 Cr (net margin 18.6%) and EBITDA of ₹33.74 Cr (EBITDA margin 29.9%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 20% over five years.
The company has about 59 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kopran. As per MCA filings, the company has open charges of ₹52.24 Cr and satisfied charges of ₹45.24 Cr on record. Court records list 10 cases involving the company, including 2 filed by the company and 8 filed against it; 2 cases are pending. The company has 7 deals on record (7 secondary share transfers); the latest was in March 2022. Its 7 peer companies in the Chemicals industry (Chemical Retail and Distribution, Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 3 smaller; the largest is Eastern Chemicals (Mumbai) Private Limited with revenue of ₹115.22 Cr.
Kopran Laboratories Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0069544). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kopranlaboratories.com.
Company details
CIN U24230MH1986PLC040602
Registration Number 040602
Incorporation Date 12 August 1986
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0069544
CIN history
Kopran Laboratories has one previous CIN (Corporate Identification Number): U24230MH1986GAP040602. The current CIN is U24230MH1986PLC040602, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1986PLC040602 | Current |
| U24230MH1986GAP040602 | Previous |
Key People
Varun Surendra Somani Managing Director Surendran Nair Director Adarsh Rajendra Somani Director Recognitions & Rankings of Kopran Laboratories
Contact details
Kopran Laboratories Limited's registered office is in Mumbai, Maharashtra. Its website is kopranlaboratories.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressParijat House1076 Dr E Moses Rd Worli, Mumbai, Maharashtra, India – 400018
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Kopran Laboratories Limited, buy the company report.
Comprehensive company report
Kopran Laboratories Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Kopran Laboratories operates one associated brand: Kopran. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical Company manufacturing a range of products | kopran.com |
Business activity
The main business activity of Kopran Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kopran Laboratories Limited, buy the company report.
Financials of Kopran Laboratories Limited
FY 2025 filings availableKopran Laboratories Limited reported revenue of ₹112.82 Cr (up 9% YoY) for FY 2025.
Revenue · FY 2025
₹112.82 Cr ▲ 9%
Net profit · FY 2025
₹20.99 Cr margin 18.6%
EBITDA · FY 2025
₹33.74 Cr margin 29.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 27%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 50%
5 years · compounded
▲ 28%
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 9% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.74 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20.99 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.9% | ||||
| Net Profit Margin | 18.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kopran Laboratories Limited, buy the company report.
Board of directors of Kopran Laboratories Limited
Kopran Laboratories has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surendran Nair | Director | 02 Aug 2024 | 2 Years 2 Months | Current |
| Adarsh Rajendra Somani | Director | 01 Sep 2015 | 11 Years 1 Months | Current |
| Rajiv Bafna Tejraj Also directs: Sarvamangal Marcantile Company Limited | Director | 02 Aug 2024 | 2 Years 2 Months | Current |
| Varun Surendra Somani Also directs: Kopran Limited, G Claridge and Company Limited, Sorabh Trading Private Limited and 5 more | Managing Director | 01 Sep 2015 | 11 Years 1 Months | Current |
| Namrata Varun Somani Also directs: Kopran Limited, Sorabh Trading Private Limited, Apurva Caplease and Finance Private Limited and 3 more | Director | 12 Feb 2015 | 11 Years 8 Months | Current |
Peer comparison
Kopran Laboratories Limited is compared with the 7 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eastern Chemicals (Mumbai) Private Limited | ₹115.22 Cr (FY 2025) | 20.0% | Mumbai, Maharashtra, India | |||
| Marlecha's Scientific & Chemicals Private Limited | ₹114.97 Cr (FY 2025) | 25.0% | Chennai, Tamil Nadu, India | |||
| Rudrashri Lifesciences Private Limited | ₹114.31 Cr (FY 2024) | 3721.0% | Gandhidham, Gujarat, India | |||
| Shriganesh Kirana Private Limited | ₹114.24 Cr (FY 2025) | -8.0% | Delhi, India | |||
| Kopran Laboratories Limitedthis company | ₹112.82 Cr (FY 2025) | ₹20.99 Cr | 18.6% | 9.0% | 59 | Mumbai, Maharashtra, India |
| K L B Instruments Company Private Limited | ₹111.47 Cr (FY 2025) | -3.0% | Delhi, India | |||
| Humsaa Exim Private Limited | ₹111.27 Cr (FY 2025) | -40.0% | Bangalore, Karnataka, India | |||
| P. Praful and Company Agency (India) Private Limited | ₹110.73 Cr (FY 2018) | 0.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Kopran Laboratories Limited, buy the company report.
Auditor
Kopran Laboratories Limited is audited by KHANDELWAL JAIN & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KHANDELWAL JAIN & CO. | FY 2023 | 105049W |
Shareholding
The shareholding of Kopran Laboratories Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kopran Laboratories Limited, buy the company report.
Charges & borrowings
Open charges
₹52.24 Cr
Satisfied charges
₹45.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Oct 2025 | 101187845 | Others | ₹2.38 Cr | Open | |
| 24 Sep 2025 | 101165324 | Yes Bank Limited | ₹71.15 Lakh | Open | |
| 31 Jul 2025 | 101136338 | Yes Bank Limited | ₹1.21 Cr | Open | |
| 26 Sep 2024 | 100989267 | Others | ₹22 Cr | Open | |
| 05 Aug 2024 | 100968536 | Others | ₹1.12 Cr | Open |
To see the full charge records of Kopran Laboratories Limited, buy the company report.
Total charge records: 28 View all charges
Deals & funding
Kopran Laboratories Limited has 7 deals on record (7 secondary share transfers); the latest was in March 2022.
Total deals
7
Secondary share transfers
7
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Bigflex Enterprises Private Limited , 3 individuals Seller: 4 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: G.Claridge & Company Limited, 3 individuals Seller: Meenul Metallizing Private Limited , Claridge Investment Limited, 2 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: Meenul Metallizing Private Limited Seller: Sarvamangal Mercantile Co.Limited |
| Dec 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Debonair Publications Private Limited |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Meenul Metallizing Private Limited , an individual Seller: Sarvamangal Mercantile Co.Limited |
To see the full deal history of Kopran Laboratories Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Kopran Laboratories Limited has 10 court cases on record: 2 filed by Kopran Laboratories, 8 filed against it. 2 cases are pending and 8 are disposed.
Total cases
10
Filed by the company
2
Filed against the company
8
Pending
2
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 4 | 1 |
| District courts | 3 | 3 | 1 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Eko Diagnostic Pvtltd | Disposed |
| District court, South Twenty Four Parganas, West Bengal | Civil suit | Filed against the company by Woodlands Multispeciality Hospital Ltd | Disposed |
| High Court of Madhya Pradesh | Writ petition | Filed by the company against The State of Madhya Pradesh | Pending |
| District court, Ahmedabad, Gujarat | Court case (SMST S) | Filed against the company by M/S. Ganesh Surgical | Pending |
| District court, Hyderabad Central, Telangana | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Kopran Laboratories Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Kopran Laboratories Limited was last rated by Crisil on 12 Mar 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 12 Mar 2020 |
To see the full credit ratings and regulatory alerts of Kopran Laboratories Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kopran Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kopran Laboratories Limited has a workforce of 59 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
59
Active EPFO establishments
1
Employee growth
-6.35%
GST
Kopran Laboratories has 5 GST registrations: 4 active and 1 cancelled or inactive.
Total GSTINs
5
Active
4
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACK4406H3ZQ | Maharashtra | Active | 01 Sep 2017 |
| 27AAACK4406H4ZP | Maharashtra | Active | 12 Jun 2025 |
| 07AAACK4406H1ZU | Delhi | Active | 01 Jul 2017 |
| 19AAACK4406H1ZP | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kopran Laboratories Limited, buy the company report.
Recent activity
Kopran Laboratories Limited has 15 board changes on record since 2011: 5 appointments and 10 cessations. The latest: Rajiv Bafna Tejraj ceased to be Additional Director on 12 Sep 2024.
Charges
A charge registered on 23 Aug 2022 via Charge ID 100615026 with Others was fully satisfied on 20 Nov 2025.
Charges
A charge registered on 21 Jun 2022 via Charge ID 100593274 with Others was fully satisfied on 20 Nov 2025.
Charges
A charge registered on 31 Mar 2022 via Charge ID 100583917 with Others was fully satisfied on 20 Nov 2025.
Charges
A charge with Others amounted to Rs. 2.38 Cr with Charge ID 101187845 was registered on 29 Oct 2025.
AGM
Kopran Laboratories Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Charges
A charge with Yes Bank Limited amounted to Rs. 0.71 Cr with Charge ID 101165324 was registered on 24 Sep 2025.
Charges
A charge with Yes Bank Limited amounted to Rs. 1.21 Cr with Charge ID 101136338 was registered on 31 Jul 2025.
Filing
Kopran Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 31 Aug 2017 via Charge ID 100152065 with Others was fully satisfied on 15 Feb 2025.
Charges
A charge with Others of Rs. 22.00 Cr registered on 26 Sep 2024 with Charge ID 100989267 was modified on 09 Dec 2024.
Charges
A charge registered on 26 Jul 2021 via Charge ID 100466068 with Yes Bank Limited was fully satisfied on 30 Sep 2024.
Charges
A charge registered on 20 Jul 2021 via Charge ID 100466066 with Yes Bank Limited was fully satisfied on 30 Sep 2024.
53 earlier events are in the company report.
Frequently asked questions
Kopran Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 12 August 1986 (40+ years old) and is registered under CIN U24230MH1986PLC040602.
Kopran Laboratories has 5 current directors:
- Varun Surendra Somani - Managing Director
- Surendran Nair - Director
- Adarsh Rajendra Somani - Director
- Rajiv Bafna Tejraj - Director
- Namrata Varun Somani - Director
The latest financial statements of Kopran Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kopran Laboratories is 27AAACK4406H3ZQ, registered in Maharashtra. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAACK4406H4ZP (Maharashtra), 07AAACK4406H1ZU (Delhi), 19AAACK4406H1ZP (West Bengal).
The CIN (Corporate Identification Number) of Kopran Laboratories is U24230MH1986PLC040602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kopran Laboratories has 10 court cases on record: 2 filed by the company and 8 filed against it. 2 are pending. Most are in the high courts.
Kopran Laboratories was incorporated on 12 August 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
Kopran Laboratories has 7 deals on record (7 secondary share transfers); the latest was in March 2022.
The peers of Kopran Laboratories by revenue are Eastern Chemicals (Mumbai) Private Limited, Marlecha's Scientific & Chemicals Private Limited, Rudrashri Lifesciences Private Limited, Shriganesh Kirana Private Limited, K L B Instruments Company Private Limited and 2 more, all in the Chemicals industry (Chemical Retail and Distribution, Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Rajiv Bafna Tejraj ceased to be Additional Director on 12 Sep 2024. Surendran Nair ceased to be Additional Director on 12 Sep 2024. Rajiv Bafna Tejraj was appointed as Director on 02 Aug 2024. Kopran Laboratories has 15 board changes on record in total.
Yes, Kopran Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0069544).